These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2952418

  • 1. Lens metabolism and cellular effects of aldose reductase.
    McLean P, Gonzalez AM, Sochor M, Hothersall JS.
    Diabet Med; 1985 May; 2(3):189-93. PubMed ID: 2952418
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H, Nozawa Y, Hayano S.
    Nippon Ganka Gakkai Zasshi; 1982 May; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract] [Full Text] [Related]

  • 3. Aldose reductase in diabetic cataracts.
    Kinoshita JH, Kador P, Catiles M.
    JAMA; 1981 Jul 17; 246(3):257-61. PubMed ID: 6787220
    [No Abstract] [Full Text] [Related]

  • 4. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
    Cheng HM, González RG.
    Metabolism; 1986 Apr 17; 35(4 Suppl 1):10-4. PubMed ID: 3083198
    [Abstract] [Full Text] [Related]

  • 5. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H, Yaginuma T, Mizuno A.
    Nippon Ganka Gakkai Zasshi; 1988 Jan 17; 92(1):194-201. PubMed ID: 3133929
    [No Abstract] [Full Text] [Related]

  • 6. Nonosmotic diabetic cataracts.
    Malone JI, Lowitt S, Cook WR.
    Pediatr Res; 1990 Mar 17; 27(3):293-6. PubMed ID: 2138728
    [Abstract] [Full Text] [Related]

  • 7. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF, Akagi Y, Kinoshita JH.
    Metabolism; 1986 Apr 17; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [Abstract] [Full Text] [Related]

  • 8. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A, Cruz E.
    Diabetes; 1985 Jan 17; 34(1):15-21. PubMed ID: 3917257
    [Abstract] [Full Text] [Related]

  • 9. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors.
    Kador PF, Akagi Y, Kinoshita JH.
    Diabet Med; 1985 May 17; 2(3):194-6. PubMed ID: 2952419
    [No Abstract] [Full Text] [Related]

  • 10. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil.
    Datiles MB, Fukui H.
    Curr Eye Res; 1989 Mar 17; 8(3):233-7. PubMed ID: 2523284
    [Abstract] [Full Text] [Related]

  • 11. NIH conference. Aldose reductase and complications of diabetes.
    Cogan DG, Kinoshita JH, Kador PF, Robison G, Datilis MB, Cobo LM, Kupfer C.
    Ann Intern Med; 1984 Jul 17; 101(1):82-91. PubMed ID: 6203454
    [Abstract] [Full Text] [Related]

  • 12. Aldose reductase, NADPH and NADP+ in normal, galactose-fed and diabetic rat lens.
    Lee SM, Schade SZ, Doughty CC.
    Biochim Biophys Acta; 1985 Sep 06; 841(3):247-53. PubMed ID: 3927985
    [Abstract] [Full Text] [Related]

  • 13. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M, Sharma YR, Cotlier E, Hollander JD.
    Invest Ophthalmol Vis Sci; 1983 Oct 06; 24(10):1426-9. PubMed ID: 6413448
    [Abstract] [Full Text] [Related]

  • 14. [Effect of insulin on aldose reductase activity in the lens of rats with streptozotocin-induced diabetes].
    Nishigami T.
    Nippon Ganka Gakkai Zasshi; 1990 Feb 06; 94(2):128-34. PubMed ID: 2114733
    [Abstract] [Full Text] [Related]

  • 15. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ, Sarges R, Aldinger CE, MacDonald DP.
    Metabolism; 1979 Apr 06; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [Abstract] [Full Text] [Related]

  • 16. The identification of aldose reductase in the pathogenesis of diabetic complications: the background.
    Kador PF, Kinoshita JH.
    Diabet Med; 1985 May 06; 2(3):187-9. PubMed ID: 2952417
    [No Abstract] [Full Text] [Related]

  • 17. Aldose reductase inhibition, glomerular metabolism, and diabetic nephropathy.
    Cohen M.
    Diabet Med; 1985 May 06; 2(3):203-6. PubMed ID: 3032499
    [No Abstract] [Full Text] [Related]

  • 18. The utilization of 13C and 31P nuclear magnetic resonance spectroscopy in the study of the sorbitol pathway and aldose reductase inhibition in intact rabbit lenses.
    Williams WF, Odom JD.
    Exp Eye Res; 1987 Jun 06; 44(6):717-30. PubMed ID: 3115803
    [Abstract] [Full Text] [Related]

  • 19. Aldose reductase in diabetic complications of the eye.
    Kinoshita JH, Fukushi S, Kador P, Merola LO.
    Metabolism; 1979 Apr 06; 28(4 Suppl 1):462-9. PubMed ID: 45423
    [Abstract] [Full Text] [Related]

  • 20. Effect of aldose reductase inhibitor on experimental diabetic cataract monitored by laser Raman spectroscopy.
    Mizuno A, Nozawa H, Yaginuma T, Matsuzaki H, Ozaki Y, Iriyama K.
    Exp Eye Res; 1987 Jul 06; 45(1):185-6. PubMed ID: 3115805
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.